Vai alla homepage

Pagina 5 - I migliori medici in Spagna — Richiedi una consulenza online

Il contenuto è conforme alla Politica editoriale di Bookimed ed è revisionato da medici

Fahad Mawlood

Josep Brugada

  • 4.7 Eccellente 441 recensioni
  • 37 anni di esperienza
  • accreditamenti:
  • Spagna, Barcellona, Centro Médico Teknon
  • Discovered the genetic cause of a rare syndrome causing sudden heart death called afterward as Brugada Syndrome.
    Has performed over 25,000 cardiac ablations.
    Has published over 350 scientific papers on cardiology.
    Has trained over 200 specialists.
    Has annual visits to Africa to treat children with arrhythmia.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Fernando Castanera de Molina

  • 4.7 Eccellente 441 recensioni
  • 29 anni di esperienza
  • accreditamenti:
  • Spagna, Barcellona, Centro Médico Teknon
  • Dr. Fernando Castanera de Molina is a specialist in ophthalmology and the Director and Founder of the Eye Clinic at Centro Médico Teknon. He is a pioneer in laser treatment for ophthalmic disorders in Spain and is an expert of glaucoma and cataracts treatment with surgical techniques and micro valves. He has provided over 100 lectures and training devoted to new techniques in cataract and refractive surgeries and is a member of several organizations such as the Spanish Society of Ophthalmology, the Spanish Society of Paediatric Ophthalmology and Strabismus, the Catalan Society of Ophthalmology, and the European Society of Cataract and Refractive Surgeons.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Eduardo Loeb Melus

  • 4.7 Eccellente 441 recensioni
  • 32 anni di esperienza
  • Spagna, Barcellona, Centro Médico Teknon
  • Work and teaching experience:

    April 2020 – present: Head of Pulmonology Service, Teknon Medical Center. Barcelona, Spain

    October 2019 – present Doctoral student at the Autonomous University of Barcelona (Doctorate in Medicine)

    December 2018 – present: Junior Physician, Pulmonology Department, El Pilar Hospital. Barcelona. Spain

    October 2018-2019. Therapist. Emergency Service of the Teknon Medical Center. Barcelona. Spain.

    March 2018 – December 2020: Data Manager of the EARCO Registry (European Collaboration on Clinical Trials Alpha-1). Coordinator of the MIDIMAR study (Characterization of the daily walking minutes variable as a useful indicator of physical activity in patients with COPD). Vall d'Hebron Research Institute (VHIR). Pulmonology Service. Vall d'Hebron University Hospital, Barcelona. Spain

    January 2018 – present: Member of the research group of the Catalan Centre of Excellence in Pulmonology Service. Vall d'Hebron University Hospital, Barcelona. Spain.

    November 2017 – February 2019: EPI-SCAN and CatCoVeR Clinical Trial Coordinator, Vall d'Hebron Research Institute (VHIR). Pulmonology Service. Vall d'Hebron University Hospital. Barcelona. Spain

    2006-2017 Pulmonologist. Head of the Pulmonology Service of the Valentina Canabal Clinical Center. Barquisimeto-Venezuela. Coordinator-Head of the Sleep and Lung Function Laboratory.

    2006-2014 Chief Physician of the Pulmonology Service of the Central University Antonio Maria Pineda. Barquisimeto-Venezuela

    2006-2013 Lecturer in the Department of Pulmonology for internal medicine residents. Faculty of Medicine. Antonio Maria Pineda Central University Hospital. Barquisimeto. Venezuela.

    2006-2008 Lecturer-Professor (position by competition). Section of Physiology. Division of Functional Sciences. Faculty of Medicine. Central Western University Lisandro Alvarado. Barquisimeto-Venezuela

    2004-2005 Teaching Fellow in the subject: Pulmonary Functional Study for the Bachelor of Cardiopulmonary Technology. Central University of Venezuela. University Hospital of Caracas. Caracas-Venezuela.

    2004-2005 Chief Resident Physician of the Pulmonology and Thoracic Surgery Service of the Central University of Venezuela. University Hospital of Caracas.

    2003-2006 Resident physician in Clinical Pulmonology at the Central University of Venezuela, University Hospital of Caracas.

    2002-2003 Chief Resident in Internal Medicine. Central Western University Lisandro Alvarado. Central University Hospital Antonio Maria Pineda

    2000-2003 Resident physician of the postgraduate course in internal medicine. Internal Medicine Service Central University Hospital Antonio Maria Pineda

    1999-2002 Faculty member and active researcher in the Physiology Section. Department of Functional Sciences, Faculty of Medicine, Universidad Centro Cidade Lisandro Alvarado

    1999-2000 Rural Doctor at Padre Oliveros Hospital. Municipality of Nirgua. State of Yaracuy, Venezuela

    1994-1998 Trainer-teacher (competitive position) Physiology Section. Department of Functional Sciences. Dean of the Faculty of Medicine. Central West University Lisandro Alvarado

    1993-1997 Research Intern at the Laboratory of Exercise Physiology Levels I, II and III of the Council for Scientific, Humanitarian and Technological Development (CDCHT) of the Central-West University “Lisandro Alvarado”.

    Experience in the pharmaceutical industry:

    Medical consultant for Pfizer Venezuela (Champix).

    Medical consultant for Boehringer Ingelheim Venezuela (SPIRIVA)

    Director of the center (principal investigator) of clinical trials of phase IIIB of Novartis and AstraZeneca.

    Qualification

    2006 Pulmonology Specialist. Central University of Venezuela. University Hospital of Caracas. Venezuela

    2003 Specialist in Internal Medicine. Central-Western University "Lisandro Alvarado" Central University Hospital Antonio Maria Pineda. Barquisimeto, Venezuela. Graduated with honors

    1998. Graduated from the Faculty of Medicine and Surgery of the Central Technological University Lisandro Alvarado, Barquisimeto-Venezuela. Graduated with honors.

    Publications

    1.- Analysis of blood biomarkers in patients with chronic obstructive pulmonary disease (COPD) and asthma-COPD co-occurrence (ACO). Gava G, Nunez A, Esquinas S, Sarasate M, Loeb E, Pirina P, Miravitles M, Barrecheguren M. COPD. 2020 Jun;17(3):306-310.

    2.- Practical guide for the identification and diagnosis of asthma-COPD overlap (ACO). Nunez A, Sarasate M, Loeb E, Esquinas S, Miravitles M, Barrecheguren M. COPD. 2019 Feb;16(1):1-7.

    3.- Nunez A, Sarasate M, Loeb E, Esquinas S, Miravitles M, Barrecheguren M. Practical guidelines for the identification and diagnosis of asthma-COPD overlap (ACO). COPD. 2019 Feb 21:1-7.

    4.- Sexual and skeletal muscle characteristics in patients with chronic obstructive pulmonary disease. Sonia J. Torres, Maria Montes de Oca, Eduardo Loeb, Abdon Mata, Noelina Hernadez. Respiratory Medicine (2011) 105, 88-94.

    5.- Lactate dehydrogenase isoenzymes in skeletal muscle of patients with COPD Sonia H. Torres, Maria Montes de Oca, Eduardo Loeb, Priva Zabner-Oziel, Valentina Wallis, Noelina Hernandez Arca Bronconeumol. 2009;45:75-80.

    6.- Peripheral Muscle Changes in Non-COPD Smokers. Maria Montes de Oca, Eduardo Loeb, Sonia J. Torres, PhD, Juan De Sanctis, Noelina Hernandez, and Carlos Talamo, MD. CHEST, January 2008, vol. 133 no. 1 13–18

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Jose Maria Raventos

  • 4.7 Eccellente 441 recensioni
  • 51 anni di esperienza
  • Spagna, Barcellona, Centro Médico Teknon
  • Dr. Jose Maria Raventos is a surgeon with 49 years of experience. He specializes in general, abdominal, endocrine, and thyroid surgery. He is known for his advanced laparoscopic skills. Dr. Raventos is also highly experienced in thyroid surgery, including complex thyroid cancer cases.

    He has made important contributions to surgical research and education. He has published many scientific articles and is active in several professional associations. Dr. Raventos earned his medical degrees from the University of Barcelona and the University of Minnesota. He completed his residencies at the Red Cross Hospital of Barcelona and the Mayo Clinic in Rochester. He is a founding member of the Teknon Medical Center faculty and the Surgical Associate Surgeons group.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Domenico Sabia

  • 4.7 Eccellente 441 recensioni
  • 24 anni di esperienza
  • accreditamenti:
  • Spagna, Barcellona, Centro Médico Teknon
  • Dr. Domenico Sabia is an experienced surgeon. He specializes in peritoneal oncology, melanoma and sarcoma surgery, laparoscopic and robotic surgery, and hepato-biliary and pancreatic surgery. He practices at Centro Médico Teknon and Consorci Sanitari Integral in Spain. Dr. Sabia has over 15 years of experience in treating advanced abdominal and pelvic cancers.

    Dr. Sabia often speaks at national and international congresses. He has written and co-written many scientific publications. He also works as an investigator in major clinical trials in oncological surgery. He is accredited by organizations such as the Asociación Española de Cirujanos and The Peritoneal Surface Oncology Group International. Dr. Sabia is also a member of several respected surgical societies.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Miquel Sans Cuffí

  • 4.7 Eccellente 441 recensioni
  • 38 anni di esperienza
  • Spagna, Barcellona, Centro Médico Teknon
  • A specialist in the digestive system through MIR from the Hospital Clinic of Barcelona and a Doctor of Medicine from the University of Barcelona, he received his PhD from the University of Barcelona.

    He completed his postgraduate training in the Gastroenterology Service of the Barcelona Hospital Clinic and then in the Department of Gastroenterology at Case Western Reserve University (Cleveland, USA), where he conducted cutting-edge research on inflammatory bowel diseases (IBD, Crohn's disease and ulcerative colitis).

    From 2004 to 2011 he worked in the Gastroenterology Department of the Barcelona Hospital Clinic / IDIBAPS, and since 2011 he has worked as a specialist doctor in the Digestive System Department of the Teknon Medical Center in Barcelona.

    He was a member of the Scientific Committee of ECCO and coordinator of the European project "IBDChip". He is the author of more than 150 publications and 500 presentations at conferences and conferences.

    Experience:

    Digestive system specialist, completed the MIR training program and completed his residency in this specialty at the Provincial Hospital of Barcelona between 1993 and 1996.

    Doctor of Medicine from the University of Barcelona with the qualification "Distinguished Diploma Unanimously". In 2001 he received the Distinguished Doctorate from the University of Barcelona.

    Between 1997 and 1999, he completed his postgraduate training in the Gastroenterology Department of the Provincial Hospital of Barcelona. Subsequently, he completed two internships in the Gastroenterology Department of Case Western Reserve University in Cleveland, USA, between 2000 and 2003, where he conducted cutting-edge research in the field of gastroenterology.

    Since 2004 he has been working in the Gastroenterology Service of the Provincial Hospital of Barcelona / IDIBAPS, focusing on the treatment and research of inflammatory bowel diseases.

    He is the author of numerous publications, conference papers and book chapters both nationally and internationally.

    Member of the Catalan Society of Gastroenterology, the Spanish Association of Gastroenterology, the Spanish Working Group on Crohn's Disease and Ulcerative Colitis and the American Gastroenterological Association.

    Areas of special interest: storage rhythm disorders, chronic diarrhea, inflammatory bowel diseases (Crohn's disease and ulcerative colitis) and other causes of chronic intestinal inflammation.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Michel Blé

  • 4.7 Eccellente 441 recensioni
  • 19 anni di esperienza
  • Spagna, Barcellona, Centro Médico Teknon
Visita dal medico
Prezzo su richiesta
Informazioni

Jordi Sasot Llevadot

  • 4.7 Eccellente 441 recensioni
  • 39 anni di esperienza
  • Spagna, Barcellona, Centro Médico Teknon
Visita dal medico
Prezzo su richiesta
Informazioni

López Gil Francisco José

  • 4.7 Eccellente 441 recensioni
  • 30 anni di esperienza
  • Spagna, Barcellona, Centro Médico Teknon
  • In 1981 he graduated from the Faculty of Medicine and Surgery of the University of Barcelona.

    Specialist in medical-surgical dermatology and venereology MIR at the Hospital del Sagrado Corazon in Barcelona in 1987.

    After completing his specialty, he worked as a doctor at the Hospital del Sagrado Corazón in Barcelona until 1993, where he gained experience in dermatological surgery and laser therapy.

    In 1994, he founded the Dermatology Department of the Teknon Medical Center, where he is currently a prominent collaborator and Medical Director. Over the years, he has created and consolidated a team of professionals with a wide range of specialties in clinical dermatology, aesthetics, oncology and laser therapy. In addition to coordinating training groups for dermatology doctors.

    In 2014, he founded the DermAndTek clinic in Andorra with the aim of providing comprehensive services in clinical and aesthetic dermatology using the latest technologies in laser therapy, prevention and treatment of skin cancer.

    The Dr. López Gil Dermatology Clinic is a team of dermatologists from the Quiróns Teknon Hospital in Barcelona, specialising in various areas of clinical dermatology, aesthetic dermatology, laser treatments, hair treatments and the latest medical technologies.

    Their specializations:

    - Clinical dermatology

    - Aesthetic dermatology

    - Oncological dermatology

    - Hair loss

    - Laser therapy

    - Excessive sweating and hyperhidrosis

    - Venereal diseases

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Volkert Boudewijn Wreesmann

  • Nuova
  • 15 anni di esperienza
  • 5000+ trattamenti eseguiti
  • Spagna, Barcellona, ANDSURGEONS Clinic
  • CURRICULUM VITAE

    VOLKERT B. WREESMANN MD PhD

    Consultant Otolaryngologist

    Oncologic Head and Neck Surgeon

    Thyroid and Parathyroid Surgeon

    Facial Plastic Surgeon

     

    Principal Positions

    • Centro Medico Teknon, Barcelona, Spain

    Lead Consultant, ANDSURGEONS ENT, Head & Neck and Facial Plastic Surgery Program (clinical service delivered in collaboration with Teknon).

    July 1st 2024 – present

     

    • Juaneda, Ciutadella Menorca, Spain

    Visiting Consultant Otolaryngologist-Head and Neck Surgeon

    January 2025 – present

     

    • Avantmedic, Lleida, Spain

    Visiting Consultant Otolaryngologist-Head and Neck Surgeon

    September 1st 2024 – November 1st 2025

     

    • Clinica Omega Zeta, Andorra

    Consultant Otolaryngologist-Head and Neck Surgeon

    March 1st 2022 – present

     

    • University Hospitals Dorset NHS Foundation Trust

    Consultant Otolaryngologist-Head and Neck Surgeon

    August 1st 2021 – October 1st 2023

     

    • Oxford University Hospitals NHS Foundation Trust

    Honorary Consultant Otolaryngologist-Head and Neck Surgeon

    May 1st 2021 – April 30th 2024

     

    • Portsmouth Hospitals University NHS Trust, Portsmouth, UK

    Consultant Otolaryngologist-Head and Neck Surgeon

    July 18th 2016 – April 30th 2021

     

    • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

    Consultant Otolaryngologist-Head and Neck Surgeon

    November 7th 2015 – May 31st 2016

     

    • Heart of England NHS Trust, Birmingham, UK

    Consultant Otolaryngologist-Head and Neck Surgeon

    March 1st 2015 – October 31st 2015

     

    • University Medical Center Utrecht, Netherlands

    Consultant Otolaryngologist-Head and Neck Surgeon

    November 1st 2013 – June 1st 2014

     

    Memberships

    • American Head and Neck Society – Member

    Netherlands Academy of Otolaryngology - Member

     

    Professional Licences

    • United Kingdom

    GMC Certification

    Fully Registered Medical Practitioner with Specialist Registration with a License to Practice

    Registered: 02/02/2015

    GMC # 7499626

     

    • United States of America

    New York State Department of Health

    New York State Education Department

    Registered: July 2011

    License# P80949

    Physician

     

    • Netherlands

    Dutch Ministry of Health (BIG Registration)

    BIG Registered: 22-06-2005

    BIG #19063373601

    Physician

     

    Dutch Specialist Board (RGS)

    RGS registered: 01-02-2011

    RGS #1911979

    Otolaryngology-Head and Neck Surgeon

     

    • Spain

    Collegi de Metges de Barcelona

    COMB: 63638

     

    • Andorra

    Collegi de Metges d’Andorra

    RPS: 03098

    COMA: 876

    Education

    • Memorial Sloan-Kettering Cancer Center

    Surgical Fellowship, Head and Neck Surgery

    New York, New York, USA

    August 1st 2011 - July 31st 2013

    600 bed dedicated cancer center

    Performed 1200 major oncologic head and neck resections in 2 years

     

    • United States of America ECFMG Certification

    United States Medical Licensing Examination (USMLE)

    Certification: June 22nd, 2010

    Scores: 

       Step I: 244/99 

       Step IIa-Clinical knowledge: 227/94

       Step IIb-Clinical Skills: PASSED

       Step III: 206/85

     

    • Netherlands Cancer Institute

    Surgical Fellowship, Head and Neck Surgery

    Amsterdam, The Netherlands

    February 1st 2011 - July 31st 2011

    Specialized Head and Neck Cancer Surgery Department

    200 bed hospital

     

    • Amsterdam University Medical Center/Netherlands Cancer Institute

    Residency Training, Otolaryngology-Head and Neck Surgery

    Amsterdam, the Netherlands

    February 1st 2006 – January 31st 2011

     

    • University of Amsterdam School of Medicine

    Medical Doctor (MD)

    Amsterdam, the Netherlands

    December 2002 - January 28th 2005

     

    • University of Amsterdam

    Doctor of Philosophy (PhD), Molecular Biology

    Amsterdam, the Netherlands

    Thesis title: Molecular-cytogenetic characterization of head and neck cancer

    December 2nd, 2004

     

    • Erasmus University School of Medicine

    Doctoral Degree in Medicine

    Rotterdam, the Netherlands

    September 1994 - November 17th, 1998

     

    Research Training

    • Memorial Sloan-Kettering Cancer Center

    Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery, New York, New York, USA

    Research Fellowship in Molecular Oncology

    Supervisors: Dr. Bhuvanesh Singh MD, PhD and Dr. Jatin P. Shah, MD, FACS

    March 1st 1999 - September 30st 2002

     

    • University of California San Francisco (UCSF)

    Department of Otolaryngology-Head and Neck Surgery, San Francisco, California, USA

    Post-doctoral Research Fellowship in Head and Neck Oncology

    Supervisors: Dr. Steven Wang MD And Prof David Eisele MD

    February 2005 - January 2006

     

    Academic Activities

    University of Amsterdam

     

    Doctorate Examination Committee member

    • September 17th, 2013 - PhD Candidate: Dr. I.J. Nixon (United Kingdom)
    • October 17th 2014 - PhD Candidate: Dr. J. Pramana (Netherlands)
    • November 17th 2015 - PhD candidate: Dr. H. van Monsjou (Netherlands)
    • December 11th 2018 - PhD Candidate: Dr. Tihana Ibrahimpasic (United States)
    • January 18th, 2021 - PhD Candidate: Dr. Laura Wang (Australia)
    • June 2nd, 2021 - PhD Candidate: Dr. Caroline Verhagen (Netherlands)

     

    Conference Faculty

    • Advanced Laryngopharyngeal Cancer: Functional Preservation and Rehabilitation, Portsmouth, June 25th - 26th, 2020 (postponed due to COVID) - Chairman
    • Functional Preservation and Rehabilitation after Treatment for Advanced Laryngeal Cancer, Portsmouth, March 14th - 15th, 2019 - Chairman
    • Portsmouth Parathyroid Conference, Portsmouth, December 14th 2018 – Chairman

     

    Editorial Roles

    • European Journal of Surgical Oncology

    Associate Editor

    January 1st 2023 – present

     

    • European Journal of Surgical Oncology

    Guest Editor

    March issue 2018, Volume 44, Issue 3, p275-378 - Special issue on thyroid cancer management

     

    • Journal of Oral Pathology and Medicine

    Guest Editor

    November issue 2021, Volume 51, Issue 10 - Special issue on vascular malformations and tumors of the head and neck

     

    • Scientific Journal Reviewer

    Oral Oncology, European Journal of Surgical Oncology, Journal of Surgical Oncology, Head and Neck, International Journal of Cancer

     

    • Scientific Project and Grant Reviewer

    Netherlands: Dutch Cancer Society

    France: Institute National du Cancer

     

    Awards

    • New York Head and Neck Society

    Annual Meeting, New York, NY, March 2002

    Title of study presented: “MUC1 is a target if 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer”

     

    Invited Lectures

    • European Society of Surgical Oncology meeting, Krakow, 2016
    • Barcelona Society of Neurosurgery, Annual Meeting, Baqueira, Spain, February, 2017
    • University of Edinburgh, Department of Otolaryngology Academic Conference, March 17th 2017
    • Medilex: Performance of Medical Specialists, Zeist, Netherlands, November 9th 2017
    • Medilex: Performance of Medical Specialists, Driebergen, Netherlands, October 11th 2017
    • Wessex Head and Neck and Thyroid Network Education Day, May 3rd, 2017
    • Portsmouth Parathyroid Conference, Portsmouth, UK, December 14th 2018
    • Global Post-laryngectomy Rehabilitation Academy, Portsmouth, UK, March 14th 2019
    • Health Care Quality Conference, Beverwijk, Netherlands, March 25th, 2019

     

    Published Research Reports

    • The growing precision of diagnostic pathways in thyroid nodule evaluation. 

    Bekker J, Wreesmann VB. 

    Eur J Surg Oncol. 2025 Jan;51(1):109374.

     

    • Special issue: Management of vascular tumors and malformations of the head and neck. 

    Oomen KPQ, Brennan PA, Wreesmann VB. 

    J Oral Pathol Med. 2022 Nov;51(10):829.

     

    • Angiosarcomas of the head and neck: Impact of large data analysis on clinical management.
    •  
    • Wreesmann VB, Oomen KP, Brennan PA.

    J Oral Pathol Med. 2022 Nov;51(10):904-910.

     

    • Current classification of vascular anomalies of the head and neck. 

    Oomen KPQ, Wreesmann VB. 

    J Oral Pathol Med. 2022 Nov;51(10):830-836.

     

    • A novel classification of carotid body tumors.

    Wreesmann VB, Nixon IJ. 

    Eur. J. Surg. Oncol. May, 2021

     

    • Management of the contralateral central neck in differentiated thyroid cancer: A contentious issue. 

    Shaha AR, Tuttle RM, Wreesmann VB. 

    Eur. J. Surg. Oncol. 2021 Apr;47(4):717-719.

     

    • Improvement of oral cancer screening quality and reach: The promise of artificial intelligence.
    •  
    • Kar A, Wreesmann VB, Shwetha V, Thakur S, Rao VUS, Arakeri G, Brennan PA.

    J Oral Pathol Med. 2020 Mar 11

     

    • The risk-benefit ratio of chemoradiation treatment in head and neck squamous cell carcinoma: value of extranodal spread and margin status. 

    Ammar M, Wreesmann VB. 

    Journal of ENT Masterclass, Yearbook 2018, Volume 11, Nr. 1, December 1st, 2018

     

    • Nasal obstruction secondary to an inverted midline supernumerary tooth. 

    Jones L, Hilton JM, Heyman J, Viswanathan H, Wreesmann VB, Hayes SM. 

    Ann R Coll Surg Engl. 2019 Jan;101(1)

     

    • Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma. 

    Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C. 

    Oncotarget. 2018 Apr 6;9(26):18198-18213.

     

    • Complete nasal obstruction secondary to pacemaker insertion. 

    Jones TL, Wreesmann VB, Nilssen E, Hilton J, Hayes SM. 

    Ann R Coll Surg Engl. 2018 May;100(5)

     

    • Optimization of the risk-benefit ratio of differentiated thyroid cancer treatment. 

    Nasef HO, Nixon IJ, Wreesmann VB. Eur J Surg Oncol. 

    2018 Mar;44(3):276-285. Review.

     

    • The risk/benefit ratio of differentiated thyroid cancer treatment: Exploring treatment de-escalation. 

    Wreesmann VB; on behalf of EJSO. 

    Eur J Surg Oncol. 2018 Mar;44(3):275.

     

    • Aggressive differentiated thyroid cancer. 

    Janjua N, Wreesmann VB. 

    Eur J Surg Oncol. 2018 Mar;44(3):367-377. Review.

     

    • Role of extracapsular nodal spread and surgical margin status in defining high-risk head and neck squamous cell carcinoma and its treatment intensity. 

    Wreesmann VB. 

    International Journal of Head and Neck Surgery, April-June 2017; 8(2): 76-83.

     

    • An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.              

    Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. 

    Thyroid. 2016 Mar;26(3):373-80.

     

    • Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. 
    •  
    • Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gönen M, Carlson D, Ganly I, Shah JP, Ghossein R, Patel SG.

    Head Neck. 2016 Apr;38 Suppl 1:E1192-9.

     

    • Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer. 

    Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP. 

    Ann Surg Oncol. 2015 Jul 28.

     

    • Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.
    •  
    • Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA.

    Thyroid. 2015 May;25(5):503-8.

     

    • Head and neck squamous cell carcinoma in young patients.

    van Monsjou HS, Wreesmann VB, van den Brekel MW, Balm AJ. 

    Oral Oncol. 2013 Dec;49(12):1097-102.

     

    • Oral and oropharyngeal squamous cell carcinomas in young patients: The Netherlands Cancer Institute experience. 

    van Monsjou HS, M Lopez-Yurda, M. Hauptmann, Balm AJ, van den Brekel MM, Wreesmann VB. 

    Head Neck. 2013 Jan;35(1):94-102.

     

    • Oropharyngeal squamous cell carcinoma: a unique disease on the rise?

    van Monsjou HS, Balm AJ, van den Brekel MM, Wreesmann VB. 

    Oral Oncol. 2010 Nov;46(11):780-5.

     

    • Closure of tracheoesophageal fistula with prefabricated revascularized bilaminar radial forearm free flap.

    Wreesmann VB, Smeele LE, Hilgers FJ, Lohuis PJ. 

    Head Neck. 2009 Jun;31(6):838-42.

     

    • Clinical impact of molecular analysis on thyroid cancer management.

    Wreesmann VB, Singh B. 

    Surg Oncol Clin N Am. 2008 Jan;17(1):1-35.

     

    Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. 

    van den Broek GB, Wreesmann VB, van den Brekel MW, Rasch CR, Balm AJ, Rao PH. 

    Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4386-91.

     

    • Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.

    Wang SJ, Wreesmann VB, Bourguignon LY. 

    Head Neck. 2007 Jun;29(6):550-8.

     

    • Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
    •  
    • Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ.

    ORL J Otorhinolaryngol Relat Spec. 2007;69(4):218-25. Epub 2007 Apr 4.

     

    • Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
    •  
    • Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R.
    •  
    • Surgery. 2006 Dec;140(6):899-905; discussion 905-6.

     

    • Repetitive endoscopic sinus surgery failure: a role for radical surgery?

    Videler WJ, Wreesmann VB, van der Meulen FW, Knegt PP, Fokkens WJ. 

    Otolaryngol Head Neck Surg. 2006 Apr;134(4):586-91.

     

    • MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas.
    •  
    • Patel KN, Maghami E, Wreesmann VB, Shaha AR, Shah JP, Ghossein R, Singh B.
    •  
    • Surgery. 2005 Dec;138(6):994-1001; discussion 1001-2.

     

    • Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities.

    Wreesmann VB, Singh B. 

    J Oral Pathol Med. 2005 Sep;34(8):449-59. Review.

     

    • Molecular profiling of tumor progression in head and neck cancer.
    •  
    • Belbin TJ, Singh B, Smith RV, Socci ND, Wreesmann VB, Sanchez-Carbayo M, Masterson J, Patel S, Cordon-Cardo C, Prystowsky MB, Childs G.
    •  
    • Arch Otolaryngol Head Neck Surg. 2005 Jan;131(1):10-8.

     

    • Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck.

    Wreesmann VB, Shi W, Thaler HT, Poluri A, Kraus DH, Pfister D, Shaha AR, Shah JP, Rao PH, Singh B. 

    J Clin Oncol. 2004 Oct 1;22(19):3965-72.

     

    • Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.

    Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

    Genes Chromosomes Cancer. 2004 Aug;40(4):355-64.

     

    • Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.

    Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein R, Singh B. 

    Cancer Res. 2004 Jun 1;64(11):3780-9.

     

    • Genetic abnormalities associated with nodal metastasis in head and neck cancer.

    Wreesmann VB, Wang D, Goberdhan A, Prasad M, Ngai I, Schnaser EA, Sacks PG, Singh B. 

    Head Neck. 2004 Jan;26(1):10-5.

     

    • Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients.
    •  
    • Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O, Pujara K, Diotti R, Carlson D, Huryn LA, Auerbach AD, Singh B.
    •  
    • J Natl Cancer Inst. 2003 Nov 19;95(22):1718-21.

     

    • Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure.

    Singh B, Wreesmann VB, Pfister D, Poluri A, Shaha AR, Kraus D, Shah JP, Rao PH. 

    BMC Genet. 2002 Nov 14;3:22. Epub 2002 Nov 14.

     

    • Genome-wide appraisal of thyroid cancer progression.
    •  
    • Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B.
    •  
    • Am J Pathol. 2002 Nov;161(5):1549-56.

     

    • Refractory chronic sinusitis: evaluation of symptom improvement after Denker’s procedure.
    •  
    • Wreesmann VB, Fokkens WJ, Knegt PP.
    •  
    • Otolaryngol Head Neck Surg. 2001 Nov;125(5):495-500.

     

    • Inflammatory pseudotumour (inflammatory myofibroblastic tumour) of the pancreas: a report of six cases associated with obliterative phlebitis.
    •  
    • Wreesmann V, van Eijck CH, Naus DC, van Velthuysen ML, Jeekel J, Mooi WJ.
    •  
    • Histopathology. 2001 Feb;38(2):105-10.

     

    • Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization.
    •  
    • Singh B, Lim D, Cigudosa JC, Ghossein R, Shaha AR, Poluri A, Wreesmann VB, Tuttle M, Shah JP, Rao PH.
    •  
    • Surgery. 2000 Dec;128(6):888-93;discussion 893-4.

     

    Abstracts (Presentations at scientific meetings):

     

    • Genome-wide screening for genetic prognostic factors in papillary thyroid carcinoma.
    •  
    • Wreesmann VB, Ghossein RA, Poluri A, Shaha AR, Tuttle RM, Shah JP Rao PH, Singh B.

    Fifth International Conference on Head and Neck Cancer San Francisco, CA, July 2000.

     

    • Hierarchical Clustering (HC): a Novel Approach to Evaluating the Prognostic Value of Laboratory Parameters in Patients (Pts) Undergoing Chemoradiation Treatment (CRT) for Advanced Laryngopharyngeal Carcinoma (LPC). 

    Singh B, Pfister D, Wreesmann VB, Li R, Gogineni S, Bosl G, Hoffman RH, Shah JP, Rao PH. 

    37th Annual Meeting of the American Society of Clinical Oncology; New Orleans LA, May 2001.

     

    • Gain of 1q is unique to the tall cell variant of papillary thyroid cancer.

    Wreesmann VB, Ghossein RA, Tuttle RM, Shaha AR, Robbins R, Shah JP, Rao PH, Singh B. 

    73rd annual meeting of the American Thyroid Association, Washington D.C. November 2001.

     

    • MUC1 is a target of 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer. 

    Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Shah JP, Rao PH, Ghossein RG, Singh B. 

    Annual Meeting of the New York Head and Neck Society, New York, NY, March 2002.

     

    • Genome wide screening identified gains and losses as independent prognostic variables in patients with head and neck squamous cell carcinoma (HNSCC). 

    Singh B, Wreesmann VB, Thaler HT, Shi W, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH. 

    38th Annual Meeting of the American Society of Clinical Oncology; Orlando, Fl May 2002.

     

    • p53 inactivation by human papillomavirus (HPV) in Fanconi anemia associated squamous cell carcinoma. 

    Kutler DI, Goberdhan A, Wreesmann VB, Giampietro PF, Auerbach AD, Singh B. 

    The Sixth Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer; Washington D.C.; October 2002.

     

    • Identification of novel prognostic factors in head and neck squamous cell carcinoma. 
    •  
    • Wreesmann VB, Shi W, Thaler HT, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH, Singh B. 

    7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

     

    • Molecular profiling of aggressive papillary thyroid cancer: prognostic significance of MUC1 alterations. 

    Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein RA, Singh B. 

    7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

     

    • Chromosomal aberrations in Fanconi anemia-associated squamous cell carcinomas differ from sporadic squamous cell carcinomas from the general population. 

    Kutler DI, Rao PH, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

    15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

     

    • Molecular classification of Fanconi anemia(FA)-associated head and neck squamous cell carcinoma (HNSCC) using oligonucleotide microarrays. 

    Kutler DI, Ganly I, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

    15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

    •  
    • Genotyping follicular cell-derived thyroid neoplasia: a CGH study of 150 cases.

    Wreesmann VB, Ghossein RA, Socci N, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

    Sixth International Conference on Head and Neck Cancer, Washington DC, August 2004.

     

    • Downregulation of Fanconi anemia genes in sporadic squamous cell carcinomas of the head and neck. 

    Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ. 

    208th meeting of the Netherlands Society of Otolaryngology-Head and Neck Surgery, Utrecht, April 7th 2006.

     

    • Extracapsular nodal spread does not predict outcome in clinically node negative oral cavity squamous cell carcinoma. 

    Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. 

    AHNS 2013 Annual Meeting, April 10 & 11, 2013, Orlando Florida.

     

    • Minor (<2mm) extracapsular spread is not an adverse predictor of outcome in metastatic squamous cell carcinoma of the oral cavity. 

    Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. 

    Presented at the AHNS 2014 Annual Meeting, July 2014, New York, New York.

     

    Books, Chapters:

     

    • Molecular Biology as applied to Head and Neck Oncology

    Wreesmann VB, Singh B.

    Stell and Maran's Textbook of Head and Neck Surgery and Oncology

    Fifth Edition

    Chapter, edited by John Watkinson and Ralph Gilbert

     

    • Molecular-Cytogenetic Characterization of Head and Neck Cancer: Identification of molecular prognostic factors and targets of therapy

    Wreesmann VB, Singh B.

    Book, Amsterdam 2004

    Reviewed in: Head and Neck: Volume 29, Issue 1, pages 82–83, January 2007

     

    • Open Conservation Surgery for Laryngeal Cancer

    Wreesmann VB, Ganly I

    Scott-Brown's Otorhinolaryngology and Head and Neck Surgery, Eighth Edition

    Chapter 27

    CRC Press, Taylor-Francis Group, June 12th, 2018

     

    • Molecular Oncology

    Wreesmann V.B.

    Self-Assessment in Head and Neck Surgery and Oncology, First Edition

    Chapter 21

    Elsevier 2014

     

    Research grants:

    Netherlands Cancer Institute “Startgeld” Grant 2008

    Project: Fanconi anemia in head and neck cancer

    Principal investigators: Wreesmann VB, van den Brekel MW, Balm AJM, Vens C.

    Amount granted: 300.000 euro

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Cásar Casado Sánchez

  • Nuova
  • 18 anni di esperienza
  • Spagna, Madrid, Ospedale Ruber Internacional
Visita dal medico
Prezzo su richiesta
Informazioni

Carmen Martínez Chamorro

  • 3.8 Buono 6 recensioni
  • Spagna, Madrid, Quironsalud Madrid
  • Dr. Carmen Martinez Chamorro is an oncohematologist who treats leukemia, lymphoma, and myeloma. She specializes in adult bone marrow transplants.

    Education

    Carmen Chamorro graduated in Medicine from the University of Valladolid, where she received the National Prize for Research in Surgery.

    She trained as a hematologist at the La Princesa University Hospital in Madrid.

    Professional experience

    From 1997 to 2007 she worked in the Clinical Hematology Department of the Rubera Hospital in Madrid.

    He is currently Deputy Head of the Hematology Department at the Quironsalud Madrid Hospital.

    Scientific activity

    Dr. Carmen Martinez Chamorro is the author of 20 medical articles and a participant in 60 international and national conferences.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Isabel Maria Blanco Herraez

  • 4.4 Buono 5 recensioni
  • 22 anni di esperienza
  • Spagna, Marbella, Quirónsalud Marbella
  • Esperta nella cura completa delle donne, si è specializzata in progetti di assistenza medica con focus sul Programma di Parto Umanizzato e lo sviluppo e la promozione di cure ostetriche a basso intervento.

    Attualmente è responsabile dell'Unità di Ostetricia e Ginecologia dell'Ospedale Quirónsalud Marbella. Ha promosso l'implementazione di un protocollo specifico per il Parto Cesareo Umanizzato in questo ospedale, per garantire la partecipazione attiva delle donne all'arrivo dei loro bambini e un piano di parto simile al parto naturale.

    La dott.ssa Blanco Herráez ha anche promosso l'implementazione dell'attuale Unità Multidisciplinare del Seno, il cui obiettivo è la gestione del cancro al seno, sia dal punto di vista preventivo che della diagnosi precoce, oltre alla diagnosi, trattamento, follow-up e recupero funzionale e psicologico dei pazienti.

     

    Formazione

    - Ospedale Son Espases Mallorca, Palma di Maiorca | 05/2007 - 05/2011 Medico Specializzando in Ginecologia.

    - Università Complutense di Madrid, Madrid 09/2000 - 06/2006. Medicina

     

    Esperienza Lavorativa

    - Ospedale Quirónsalud Marbella - Responsabile dell'Unità di Ginecologia e Ostetricia | 04/2022 – In Corso

    - Ospedale Universitario Fundación Jiménez Díaz - Consulente di Ostetricia e Ginecologia | 06/2011 - 04/2022

    - Ospedale Universitario Fundación Jiménez Díaz - Insegnamento a Specializzandi in Ostetricia e Ginecologia 06/2012- 06/2014.

    - Ospedale Universitario Fundación Jiménez Díaz - Docente Collaboratore 06/2016- 06/2022

    Affiliazioni

    - Membro dell'Ordine dei Medici Professionali di Madrid da giugno 2011.

    - Membro della Società Spagnola di Ostetricia e Ginecologia da ottobre 2008.

    - Membro della Società Spagnola di Patologia Cervicale e Colposcopia dal 2011.

     

    L'obiettivo principale dell'Unità di Ostetricia e Ginecologia dell'Ospedale Quirónsalud Marbella è quello di fornire un servizio di assistenza completa di alta qualità alle donne e alle loro problematiche di salute in qualsiasi fase della loro vita. In particolare, le questioni derivanti dalla gravidanza, il parto e la fase post-parto, nonché qualsiasi questione relativa agli organi femminili e alle funzioni riproduttive.

    Un team multidisciplinare altamente qualificato che pone ogni paziente al centro per garantire la fornitura di un servizio professionale e personalizzato, adattato alle esigenze di salute e alle aspettative delle donne. Inoltre, una diagnosi precoce e un trattamento personalizzato per ogni circostanza personale, la promozione della salute e la prevenzione delle malattie sono al centro del lavoro dell'Unità di Ostetricia e Ginecologia.

    Efficienza, innovazione, utilizzo di nuove tecnologie e digitalizzazione sono fattori differenziali del servizio di assistenza fornito dagli oltre 30 professionisti della salute (medici, infermieri, infermieri assistenti e ostetriche) che compongono il team di questa specialità.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Erika María Torres San Narciso

  • 4.3 Buono 4 recensioni
  • 16 anni di esperienza
  • Spagna, Alicante, Quironsalud Torrevieja
  • Specialista in neurologia
    Responsabile del dipartimento di neuroscienze avanzate – Quirónsalud

    Esperienza professionale

    Capo del servizio di neurologia
    Ospedale Universitario di Torrevieja (2018–2021)
    Ha guidato un team multidisciplinare di neurologia, dedicando particolare attenzione alla cura dei pazienti, soprattutto con malattie neurodegenerative.

    Capo del servizio di neurologia
    Clinica Hospital Benidorm (2017 – 2018)
    Ha gestito i servizi diagnostici e terapeutici nel campo della neurologia generale, dell'epilessia e dei disturbi del movimento.

    Neurologo consulente
    Ospedale Generale Universitario di Alicante (2017 – 2018)
    Si è specializzato in assistenza neurologica in regime di degenza e ambulatoriale, partecipando attivamente ad attività didattiche e di ricerca.

    Neurologo consulente
    Ospedale di Manises, Valencia (2016 – 2017)
    Concentrazione principale su epilessia e diagnosi neurologiche complesse.

    Medico generico
    Fondazione benefica Baghavatula (BCT), Visakhapatnam, India (2012–2016)
    Ha fornito servizi medici a comunità rurali svantaggiate, acquisendo un'esperienza preziosa nella medicina globale.

    Formazione ed istruzione

    Laurea in Medicina
    Università Autonoma di Madrid (UAM) (2005–2011)

    Residency in Neurologia (programma MIR)
    Ospedale Generale Universitario di Alicante (2012–2016)

    Formazione post-laurea

    Specializzazione post-laurea in disturbi del movimento
    Universitat Oberta de Catalunya (2019 – 2020)

    Specializzazione post-laurea in ricerca clinica
    Cattedra UAM-Abbvie (2020 – presente)

    Master in gestione sanitaria
    UDIMA - Università a Distanza di Madrid (2020 – in corso)

    Master in neurologia clinica
    Università Francisco de Vitoria (2020 – presente)

    Società professionali

    Membro di Sociedad Valenciana de Neurología (SVN)

    Membro di Sociedad Española de Neurología (SEN)

    Contributi scientifici

    Pubblicazioni:

    «Malattia di Creutzfeldt-Jakob – variante Heidenhain» – Relazione al 66° incontro della Sociedad Española de Neurología (2015)

    «Lonatanismo o epilessia?» – Relazione al 39° convegno annuale della Sociedad Española de Neuropediatría (2016)

    Conferenze e corsi:

    Corso di trattamento ospedaliero dell'epilessia – Ospedale La Princesa, Madrid (2020)

    Aggiornamenti sul morbo di Parkinson e disturbi del movimento – Società dei disturbi del movimento, 2019

    Riunione annuale della American Epilepsy Society – Baltimora, USA (2019)

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Mireia Ruiz Castilla

  • 4.4 Buono 6 recensioni
  • 16 anni di esperienza
  • Spagna, Barcellona, Hospital Quiron Barcelona
  • Dr. Ruiz Castilla is a prestigious specialist in plastic, aesthetic and reconstructive surgery, ranked among the top 5 plastic surgeons in Spain by Forbes magazine in 2018, 2019 and 2020. She has more than 15 years of experience in the profession and extensive training in various specialties. In this sense, he has extensive experience in the medical and surgical treatment of breast pathology, skin oncology, burns, facial fractures, hand surgery and skin changes, using both traditional and microsurgical techniques.

    She is currently Head of the Plastic, Reconstructive and Aesthetic Surgery Service at the Quironsalud Hospital of Barcelona and Head of the Plastic Surgery Service at the Dexeus University Hospital since November 2021.

    Throughout his career, he has combined public health work with teaching, and has also carried out important outreach and research work. She has authored and co-authored numerous scientific articles and publications, and is a regular speaker at specialized conferences. She is also involved as an investigator in several lines of research in the field of monitoring and using new treatments for burn patients.

    Dr. Ruiz has practiced in prestigious national and international centers and currently directs her own Institute of Plastic, Reconstructive and Aesthetic Surgery, Institut Ruiz Castilla.

    Professional experience

    1998–2004: Degree in Medicine and Surgery at the Autonomous University of Barcelona

    2005–2010: Specialized residency in plastic, reconstructive and aesthetic surgery

    2009-2010: Master's degree entitled "Expert in Microsurgical Techniques. XII Theoretical and Practical Course in Microsurgical Techniques". Hand and Peripheral Nerve Surgery Department, Sabadell Hospital. (Director: Dr. J. Ramon Solé)

    2018 PhD in Surgery - Autonomous University of Barcelona: "The role of the IL33/ST2 axis in burn patients", unanimously awarded Summa Cum Laude.

    2018 Robotic Surgery Course at the Faculty of Medicine, University of Lorraine, France.

    Professional career

    2016 – present: Head of Service, Department of Plastic, Reconstructive and Aesthetic Surgery, Quirónsalud Barcelona Hospital

    2010 – 2018 Specialist in the Plastic, Reconstructive and Burns Surgery Service at the Vall d'Hebron University Hospital.

    2013 – 2017 Specialist in Plastic, Reconstructive and Aesthetic Surgery at the Obstetrics and Gynecology Center, Mataró.

    Extensive experience in medical and surgical treatment of breast pathology, skin oncology, burns, facial fractures, hand surgery and altered skin using both traditional and microsurgical methods.

    Participation in the world's first total face transplant.

    Participation in the second face transplant at the Vall d'Hebron Hospital.

    Membership in scientific societies

    Member of the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery

    Member of the Catalan Society of Plastic, Reconstructive and Aesthetic Surgery

    Member of the American Society of Plastic Surgeons

    Founding member of the Women's Organization of Plastic, Reconstructive and Aesthetic Surgery of Spain (WOPRASS).

    Research and Teaching

    Teaching Assistant for the Plastic Surgery Course at the Faculty of Medicine at the Autonomous University of Barcelona (Teaching Unit: Vall d'Hebron)

    Lecturer in the course on comprehensive care of burn patients, part of the postgraduate course entitled "Nursing care for people with burns", University Hospital Vall d'Hebron

    Lecturer in the course on comprehensive treatment of burn patients (Josep Trueta University Hospital) 2010

    Organiser of the International Conference on Plastic and Cosmetic Surgery, London, 11-12 March.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Pietro di Mauro

  • 4.4 Buono 5 recensioni
  • Spagna, Marbella, Quirónsalud Marbella
  • Pietro di Mauro is a plastic, aesthetic and reconstructive surgeon.

    Education

    Virgen de las Nieves University of Granada, Spain.

    Professional experience

    He completed an internship at the Kiron Clinic in Madrid and Westminster Hospital in London.

    Membership in organizations

    • Spanish Society of Plastic and Aesthetic Surgery SECPRE.
  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Antonio Gil-nagel Rein

  • Nuova
  • 76 anni di esperienza
  • Spagna, Madrid, Ospedale Ruber Internacional
  • Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

    More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

    The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

    Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

    He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

    Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

    In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

    In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

    Education

    • 1985Bachelor of Medicine and Surgery , Complutense University of Madrid.
    • 1986-1989Specialization in Neurology , Hospital 12 de Octubre, Madrid.
    • 1991–1993Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
    • 1997Certification of the American Board of Clinical Neurophysiology .

    Professional experience

    • 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
    • 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
    • Since 1998Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
    • 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
    • 2022Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

    Membership in professional societies

    • Since 1991 – Member of the American Academy of Neurology (AAN).
    • Since 1991 – Member of the American Epilepsy Society (AES).
    • Since 1996 – Member of the American Society of Clinical Neurophysiology .
    • Since 1988 – Member of the Spanish Society of Neurology .
    • Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
    • Since 2006 – Member of the editorial committee and the WFN web portal .
    • Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
    • Since 2009 – Member of the EFNS Educational Courses Committee.
    • 2007–2009 – Member of the EFNS Scientific Committee .
    • 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
    • 2004–2007 – Delegate of Spain to the EFNS .
    • 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

    Outstanding Achievements

    Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

    Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Bruce Patrik Dos Santos Marcano

  • 4.4 Buono 6 recensioni
  • 16 anni di esperienza
  • Spagna, Barcellona, Hospital Quiron Barcelona
  • Some words about me

    My interest in plastic surgery arose from a passion for creative work that requires solutions, an individual approach and a commitment to excellence.

    I have been fortunate to work with outstanding specialists who possess not only high technical skills but also exceptional human qualities. My goal is to match this level and apply the best methods in my practice.

    I am currently part of a young and dynamic team of motivated professionals dedicated to providing the highest quality of medical care to our patients.

    Education and qualifications

    🔹 Specialist in Plastic, Aesthetic and Reconstructive Surgery (MIR training) - Vall d'Hebron University Hospital, Barcelona
    🔹 Clinical Biochemistry Specialist (MIR training) – Comprehensive University Hospital of A Coruña
    🔹 Master in Aesthetic Medicine and HealthUniversity of Barcelona
    🔹 Master in Integration and Clinical Problem Solving in MedicineUniversity of Alcalá
    🔹 Master in Biostatistics, Informatics and Telemedicine in Clinical Practice and Health ManagementUNED
    🔹 Master in Molecular Biology and Cellular GeneticsUniversity of A Coruña
    🔹 Biostatistician and Medical Research Analysis SpecialistUNED
    🔹 Expert in statistics and interpretation of medical researchUNED
    🔹 Health informatics and telemedicine expertUNED
    🔹 Diploma in Scientific Research MethodologyOMS Training Fund
    🔹 Microsurgical Technique CourseParc Taulí Foundation, Sabadell
    🔹 Medical and Surgical DegreeCentral University of Venezuela

    Professional activity

    🔹 Worked in public and private medical centers as a specialist and teacher:
    University Hospital of A Coruña
    Virgen de Xunqueira Hospital
    Imperial College London
    Quirónsalud Hospital Barcelona (currently)

    Membership in professional associations

    College of Physicians of Barcelona
    General Medical Council (UK)
    Member of the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery (SECPRE)
    Member of the Catalan Society of Plastic, Reconstructive and Aesthetic Surgery (SCCPRE)
    Member of the American Society of Plastic Surgeons (ASPS)

    📌 Participation in numerous courses and congresses on plastic and aesthetic surgery.
    📌 Author and co-author of scientific publications , including a chapter in a specialized medical book.

    🔗 SECPRE – Spanish Society of Plastic Surgery
    🔗 SCCPRE – Catalan Society of Plastic Surgery
    🔗 American Society of Plastic Surgeons (ASPS)

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Inmaculada Gómez Arrayás

  • Nuova
  • 34 anni di esperienza
  • Spagna, Madrid, Ospedale Ruber Internacional
  • Professional experience

    • 2018 – present : Head of the Traumatology Department at the International Orthopaedic Center Hospital Ruber Internacional in Madrid.
    • 2000 – 2018 : Specialist in Hip and Knee Surgery at the International Center Hospital Ruber Internacional, Madrid.
    • Until 2000 : Deputy Head of the Traumatology Department at the Hospital J. Puerta de Hierro, Madrid.

    Education and qualifications

    • 1992 : Medical degree from the Faculty of Medicine and Surgery of the Autonomous University of Madrid.
    • Specialization in Orthopedic Surgery and Traumatology at the Puerta de Hierro Hospital.

    Scientific research and clinical trials

    1. Phase 2B : Efficacy and safety study of PD 0348292 for the prevention of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty.
    2. CV185-047 : Comparison of the efficacy of apixaban and enoxaparin for the prevention of VTE.
    3. CV185-035 : A study of prevention of deep vein thrombosis after hip replacement.
    4. PRADAXA® 1160.85 : A study of the efficacy of dabigatran etexilate for the prevention of VTE following hip and knee surgery.
    5. PRADAXA® 1160.84 : Evaluation of the safety of dabigatran in patients with moderate renal impairment after total renal arthroplasty.

    Learning and Teaching

    • 1997–2000 : Associate Professor, Department of Traumatology, Puerta de Hierro Hospital, Madrid.

    Specialization and innovation

    • Knee replacement : Using the latest generation navigation systems, Rapid Recovery and ERAS protocols for accelerated recovery.
    • Hip Replacement : Minimally Invasive Techniques and Improved Restorative Protocols.
    • Arthroscopic surgery : Treatment of diseases of the knee and hip joints.
    • Non-surgical treatment : Introduction of innovative infiltration techniques for joint pathology.

    Recognition and achievements

    • 2022 : Included in the Forbes list as one of the 100 best doctors in Spain , recognized for leadership and innovation in joint surgery using navigation technologies.
    • Since 2008 : ISO 9001:2008 certification for quality of hip and knee replacement surgeries.

    Membership in professional organizations

    • International Member of the American Academy of Orthopaedic Surgeons .
    • Member of the Spanish Association of Arthroscopy .

    The doctor has established himself as a pioneer in the field of joint surgery, introducing innovative technologies such as navigation systems and minimally invasive approaches. His achievements and approach to patient recovery make him one of the leading specialists in Spain.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni

Enriqueta Felip

  • 4.4 Buono 6 recensioni
  • 39 anni di esperienza
  • accreditamenti:
  • Spagna, Barcellona, Hospital Quiron Barcelona
  • Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.

    She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.

  • Mostra di più
Visita dal medico
Prezzo su richiesta
Informazioni